In a series of 301 renal homograft recipients, 17 (5.6%) had acute pancreatitis at some time after transplantation. Eleven of these patients died, for a mortality of 64.7%. In each instance, pancreatitis was a major factor in a complex chain of lethal events to which immunosuppression invariably contributed. An additional 43 patients (14.3%) developed asymptomatic hyperamylasemia after transplantation and, undoubtedly, some of these recipients also had pancreatitis. The factors causing pancreatitis in the renal transplantation patient include uremia, hyperparathyroidism, pancreatic injury by drugs, infections resulting from chronic immunosuppression, gallstones, and operative trauma to the pancreas. In cases of preexisting pancreatitis, transplantation is not necessarily precluded, but efforts should be made to find a specific cause of the pancreatitis and take corrective measures, such as biliary tract surgery or parathyroidectomy if indicated, in advance of transplantation.
Penn I, Durst AL, Machado M, Halgrimson CG, Booth AS, Putman CW, Groth CG, Starzl TE. Acute Pancreatitis and Hyperamylasemia in Renal Homograft Recipients. Arch Surg. 1972;105(2):167–172. doi:10.1001/archsurg.1972.04180080021004
Customize your JAMA Network experience by selecting one or more topics from the list below.